Literature DB >> 1481344

Chronic valvular disease in the cavalier King Charles spaniel in Sweden.

J Häggström1, K Hansson, C Kvart, L Swenson.   

Abstract

The prevalence of chronic valvular disease was studied in 494 cavalier King Charles spaniels with a mean (+/- sd) age of 3.0 +/- 2.7 years. Cardiac murmurs were detected in 65 (13.2 per cent) of the dogs. Among 61 cavalier King Charles spaniels with a mean age of 6.4 +/- 2.8 years, cardiac murmurs were detected in 32 (52 per cent). In both groups of dogs the prevalence of cardiac murmurs was low among dogs younger than three years (1.9 per cent) but increased with age (P < 0.001). The estimated ages at which 50 per cent of the dogs had developed murmurs were 7.5 and 6.2 years, respectively. When 39 of the 61 dogs were re-examined three years later, cardiac murmurs were detected in 28 (72 per cent), and the intensities of the murmurs had generally increased (P < 0.05). Nine (28 per cent) of the dogs which had previously had murmurs had been euthanased for signs of congestive heart failure whereas none of the dogs which had been free of murmurs had died from congestive heart failure. Animal insurance statistics from 1982 to 1990 (1983 excluded) for dogs less than 10 years old showed that claims for veterinary care or death or euthanasia were five times more common in the cavalier King Charles spaniel than in dachshunds (P < 0.001) and eight times more common than the mean for all other insured breeds (P < 0.001).

Entities:  

Mesh:

Year:  1992        PMID: 1481344

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  22 in total

1.  Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs.

Authors:  H D Pedersen
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

2.  Evaluation of the Swedish breeding program for cavalier King Charles spaniels.

Authors:  Tobias Lundin; Clarence Kvart
Journal:  Acta Vet Scand       Date:  2010-09-23       Impact factor: 1.695

3.  Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency.

Authors:  Sung-Taek Ahn; Sang-Il Suh; Hyeongsun Moon; Changbaig Hyun
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

Review 4.  Insurance data for research in companion animals: benefits and limitations.

Authors:  Agneta Egenvall; Ane Nødtvedt; Johanna Penell; Lotta Gunnarsson; Brenda N Bonnett
Journal:  Acta Vet Scand       Date:  2009-10-29       Impact factor: 1.695

5.  Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.

Authors:  H D Pedersen; B O Kristensen; K A Lorentzen; J Koch; A L Jensen; A Flagstad
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

6.  Evaluation of artificial selection in Standard Poodles using whole-genome sequencing.

Authors:  Steven G Friedenberg; Kathryn M Meurs; Trudy F C Mackay
Journal:  Mamm Genome       Date:  2016-08-10       Impact factor: 2.957

7.  Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates.

Authors:  B N Bonnett; A Egenvall; A Hedhammar; P Olson
Journal:  Acta Vet Scand       Date:  2005       Impact factor: 1.695

8.  Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England.

Authors:  Jennifer F Summers; Dan G O'Neill; David B Church; Peter C Thomson; Paul D McGreevy; David C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2015-04-18

9.  Clinical severity score system in dogs with degenerative mitral valve disease.

Authors:  J López-Alvarez; J Elliott; D Pfeiffer; Y-M Chang; M Mattin; W Moonarmart; M J Hezzell; A Boswood
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

10.  Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.

Authors:  M J Reimann; J Häggström; A Mortensen; J Lykkesfeldt; J E Møller; T Falk; L H Olsen
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.